SynGen Obtains $5,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2125 19th Street Sacramento, CA 95818 USA
  • Company Description
    We are in the business of inventing and commercializing products that utilizes single-use sterile plastic cartridge disposables and dedicated, highly automated mechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The latest financing will allow us to make our first sales of the SynGenX™-1000 System to cord blood banks, and to continue to commercialize the SynGenX-Lab and CellWashPRO devices for stem cell processing customers.
  • M&A Terms
  • Venture Investor

Trending on Xconomy